List your company

RoI-level Breast Cancer Tumor Subtyping on BRACS (test)

90.78AUROC (Test)GrapHist
45.48857.246569.00580.7635Feb 24, 2026

Evaluation results

MethodLinks
GrapHistAggregation=add-ABMIL2026.0290.78—
GrapHistAggregation=conj-ABMIL2026.0290.04—
GrapHistAggregation=ABMIL2026.0289.99—
MAEAggregation=add-ABMIL2026.0288.98—
MAEAggregation=conj-ABMIL2026.0286.24—
MAEAggregation=ABMIL2026.0286.23—
DINOv2Aggregation=add-ABMIL2026.0285.65—
DINOv2Aggregation=ABMIL2026.0283—
DINOv2Aggregation=conj-ABMIL2026.0281.91—
ACM-bioAggregation=add-ABMIL2026.0263.08—
ACM-UNIAggregation=add-ABMIL2026.0262.77—
ACM-bioAggregation=ABMIL2026.0257.13—
ACM-bioAggregation=conj-ABMIL2026.0255.42—
ACM-UNIAggregation=conj-ABMIL2026.0254.8—
ACM-UNIAggregation=ABMIL2026.0247.23—
ACM-bioModel Category=Supervised graph models, MIL aggregation=best variant2026.02—21.55
ACM-UNIModel Category=Supervised graph models, MIL aggregation=best variant2026.02—19.95
DINOv2Model Category=Self-supervised vision models, MIL aggregation=best variant2026.02—52.68
GrapHistModel Category=Ours, MIL aggregation=best variant2026.02—60.3
MAEModel Category=Self-supervised vision models, MIL aggregation=best variant2026.02—56.33